Paragon 28, Inc. (FNA)
NYSE: FNA · Real-Time Price · USD
10.03
+0.23 (2.35%)
Dec 20, 2024, 4:00 PM EST - Market closed

Paragon 28 Revenue

Paragon 28 had revenue of $62.34M in the quarter ending September 30, 2024, with 18.10% growth. This brings the company's revenue in the last twelve months to $245.00M, up 18.16% year-over-year. In the year 2023, Paragon 28 had annual revenue of $216.39M with 19.30% growth.

Revenue (ttm)
$245.00M
Revenue Growth
+18.16%
P/S Ratio
3.40
Revenue / Employee
$426,821
Employees
574
Market Cap
839.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023216.39M35.01M19.30%
Dec 31, 2022181.38M33.92M23.00%
Dec 31, 2021147.46M36.48M32.87%
Dec 31, 2020110.98M4.70M4.42%
Dec 31, 2019106.28M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 5.59B
Healthcare Services Group 1.70B
Cytek Biosciences 201.21M
Avid Bioservices 150.45M
Prothena Corporation 133.35M
Immatics 128.82M
AbCellera Biologics 32.96M
Revenue Rankings